Featured Research

from universities, journals, and other organizations

Anti-aging gene identified as tumor suppressor in mice: Mice without pro-longevity gene SIRT6 had higher risk of gastrointestinal cancers

Date:
December 11, 2012
Source:
University of Michigan Health System
Summary:
A new study sheds more light on how an anti-aging gene suppresses cancer growth, new research shows.

A new study sheds more light on how an anti-aging gene suppresses cancer growth, joint University of Michigan Health System and Harvard Medical School research shows.

Loss of the SIRT6 protein in mice increases the number, size and aggressiveness of tumors, according to the new research published in the scientific journal Cell. The study also suggests that the loss of SIRT6 promotes tumor growth in human colon and pancreatic cancers.

"It is critical to understand the spectrum of genes that suppress tumor development," says co-senior author David Lombard, M.D., Ph.D., assistant professor of pathology and assistant research professor at the U-M Institute of Gerontology at the U-M Medical School.

"Our research suggests SIRT6 may have a critical role in blocking cancer and controlling cellular metabolism. We hope to build on this work to better understand how this protein suppresses tumor development, and provide insight into potential future means of reprogramming cancer metabolism."

The research was done in conjunction with the Massachusetts General Hospital Cancer Center at Harvard Medical School. Raul Mostoslavsky, M.D., Ph.D., assistant professor of medicine at Harvard Medical School, was the co-senior author.

The new research highlights the role SIRT6 plays in dampening cancer growth by repressing aerobic glycolysis -- a major feature of cancer cells that involves the conversion of glucose to lactate. SIRT6 also inhibits activity of the key cancer gene Myc.

Many studies in cancer biology have focused on the importance of tumor suppressor proteins and how they may protect cells from progressing to cancer.

The new research follows up on previous studies that have tied SIRT6 to longevity in male mice. Other research has also shown that the protein may protect against diet-induced obesity.

"This work points to the conservation of biological mechanisms between lower organisms and humans, and the importance of fundamental basic research," says Lombard, a researcher at the U-M Comprehensive Cancer Center. "This family of proteins was originally studied in yeast. It turns out to have key roles in promoting mammalian health."

National Institutes of Health (Awards GM093072-01, DK088190-01A1 and GM101171); University of Michigan Comprehensive Cancer Center, Ellison Medical Foundation, Pardee Foundation, Sidney Kimmel Cancer Research Foundation.

Mostoslavsky is a member of the Scientific Advisory Board of Sirtris, a company that is attempting to develop sirtuin-directed therapeutics.


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Carlos Sebastián, Bernadette M.M. Zwaans, Dafne M. Silberman, Melissa Gymrek, Alon Goren, Lei Zhong, Oren Ram, Jessica Truelove, Alexander R. Guimaraes, Debra Toiber, Claudia Cosentino, Joel K. Greenson, Alasdair I. MacDonald, Liane McGlynn, Fraser Maxwell, Joanne Edwards, Sofia Giacosa, Ernesto Guccione, Ralph Weissleder, Bradley E. Bernstein, Aviv Regev, Paul G. Shiels, David B. Lombard, Raul Mostoslavsky. The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism. Cell, 2012; 151 (6): 1185 DOI: 10.1016/j.cell.2012.10.047

Cite This Page:

University of Michigan Health System. "Anti-aging gene identified as tumor suppressor in mice: Mice without pro-longevity gene SIRT6 had higher risk of gastrointestinal cancers." ScienceDaily. ScienceDaily, 11 December 2012. <www.sciencedaily.com/releases/2012/12/121211113001.htm>.
University of Michigan Health System. (2012, December 11). Anti-aging gene identified as tumor suppressor in mice: Mice without pro-longevity gene SIRT6 had higher risk of gastrointestinal cancers. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/12/121211113001.htm
University of Michigan Health System. "Anti-aging gene identified as tumor suppressor in mice: Mice without pro-longevity gene SIRT6 had higher risk of gastrointestinal cancers." ScienceDaily. www.sciencedaily.com/releases/2012/12/121211113001.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins